Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use

Table 4 Linear regression models estimating the association between the number of followers and SABA use among Propeller users with over 1 day of use (n = 59)

	Number of Followers	N (Number of Patients)	Estimate	Std. Error	P
SABA-free days	1 (reference)^a	21	–	–	–
	2–3	19	3%	5%	0.62
	> 3	19	9%	5%	0.09
SABA Use (mean puffs/day)	1 (reference)^a	21	–	–	–
	2–3	19	-0.02	0.25	0.94
	> 3	19	-0.44	0.25	0.08

LInear regression assumptions were checked with residual plots and histograms and were deemed satisfactory
^aThose with 1 follower, the reference group, all had a caregiver as their follower. Those with over 1 follower had one caregiver and at least one physician follower

ISSN: 2054-7064